Patents by Inventor Youli Zhang

Youli Zhang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210112288
    Abstract: Embodiments of the present disclosure provide network live-broadcasting methods and devices. The method can include: obtaining live-broadcasting data from a server side; obtaining service data from the server side; determining whether the obtained live-broadcasting data contains key information, wherein the key information is inserted by a live-broadcasting side in the live-broadcasting data when predetermined content corresponding to the service data is included in the live-broadcasting data; and outputting, in response to receiving the key information, the service data on a playing interface of the live-broadcasting data, so that the service data is output synchronously with the predetermined content.
    Type: Application
    Filed: November 30, 2020
    Publication date: April 15, 2021
    Inventors: Jufeng CHEN, Yuhong GUAN, Changding LIU, Gaowei CHANG, Jie SHI, Wentao WAN, Shuncai MIAO, Chen BI, Peifeng LIU, Yi XIE, Youli ZHANG, Dong QIN, Chuan YANG, Qingfeng LAI
  • Patent number: 9670213
    Abstract: Provided are a pteridine ketone derivative used as an EGFR, BLK, and FLT3 inhibitor and applications thereof. Specifically, provided are a compound of the following formula I, a pharmaceutical composition containing the compound of the formula I, and use of compound in preparing medicine for treating diseases mediated by EGFR, BLK, or FLT3 or inhibiting EGFR, BLK, and FLT3.
    Type: Grant
    Filed: April 2, 2013
    Date of Patent: June 6, 2017
    Assignee: East China University of Science and Technology
    Inventors: Honglin Li, Yufang Xu, Zhenjiang Zhao, Xiaofeng Liu, Wei Zhou, Fang Bai, Mengzhu Xue, Lei Zhang, Youli Zhang
  • Publication number: 20150126508
    Abstract: Provided are a pteridine ketone derivative used as an EGFR, BLK, and FLT3 inhibitor and applications thereof. Specifically, provided are a compound of the following formula I, a pharmaceutical composition containing the compound of the formula I, and use of compound in preparing medicine for treating diseases mediated by EGFR, BLK, or FLT3 or inhibiting EGFR, BLK, and FLT3.
    Type: Application
    Filed: April 2, 2013
    Publication date: May 7, 2015
    Inventors: Honglin Li, Yufang Xu, Zhenjiang Zhao, Xiaofeng Liu, Wei Zhou, Fang Bai, Mengzhu Xue, Lei Zhang, Youli Zhang